CARDIO RING TECNNOLOGIES,INC.
Update：2026/01/30
Industries
Main Industry
Health Care
Main Product/Service
The flagship product of the company is the ArteVu CNBP Monitoring System, a breakthrough continuous non-invasive blood pressure (CNBP) monitor. Utilizing a comfortable finger-clip design and patented sensor technology, it delivers real-time arterial waveform analysis and heart rate insights every two seconds with near-catheter precision (average error <5 mmHg). Engineered for versatile clinical settings such as operating rooms, ICUs, and dialysis centers, ArteVu provides a painless alternative to invasive arterial lines and repeated cuff inflations, ensuring high accuracy regardless of skin tone or ambient light.
Founded Year
1900
Unified Business No.
83248817
Status
Active
Number of Employees
20
Total Paid-in
Capital
0 (NT$)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Cardio Ring Inc. is a pioneering medical technology company headquartered in San Jose, USA, with a specialized branch in Taipei, Taiwan. The company is dedicated to revolutionizing hemodynamic monitoring through advanced semiconductor sensors and proprietary algorithms. With a commitment to clinical excellence, Cardio Ring has achieved significant regulatory milestones, including FDA 510(k) clearance and TFDA registration, aiming to provide healthcare professionals with high-precision, non-invasive diagnostic tools that enhance patient safety and clinical decision-making.
